Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,552.40
(
0.14%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
97.45
(
0.68%
)
Bitcoin
71,244.00
(
0.49%
)
News Focus
News Focus
Post# of 257273
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: frontiers post# 179178

Thursday, 06/12/2014 9:38:23 AM

Thursday, June 12, 2014 9:38:23 AM

Post# of 257273

ACHN—If you have bothered to review the preclinical data for [ACH-3422] compared to sofosbuvir, you will see that 3422 is equal to better than sofosbuvir.

Please specify the dataset you are referring to and provide a link. T.i.a.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today